Pediatr Crit Care Med 13(Suppl 1):S1S82 Kochanek PM, Jackson TC, Ferguson NM, Carlson SW, Simon DW, Brockman EC, Ji J, Bayir H, Poloyac SM, Wagner AK, Kline AE, Empey PE, Clark RS, Jackson EK, Dixon CE (2015) Emerging therapies in traumatic brain injury
The findings of subgroup analyses were similar to the overall results for each variable and revealed no significant SMD
This raises concern in patients undergoing sedated medical procedures such as EGD or colonoscopy
Our quality assurance process includes: HPLC Analysis confirms peptide purity exceeding 99% Mass Spectrometry (MS) verifies molecular identity and sequence integrity Endotoxin Testing ensures product is free from bacterial endotoxins Certificate of Analysis (CoA) available for every batch upon request We are committed to supplying researchers with the highest-grade peptides available on the market